Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (3)
Type
Type
Guidance (109)
NICE advice (14)
Quality standard (9)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (1)
Clinical guidelines (14)
Diagnostics guidance (3)
Highly specialised technologies guidance (4)
Interventional procedures guidance (17)
Medical technologies guidance (10)
NICE guidelines (20)
Public health guidelines (4)
Social care guidelines (3)
Technology appraisal guidance (55)
Advice programme
Advice programme
Evidence summaries (2)
Medtech innovation briefings (12)
Apply filters
Showing 21 to 30 of 132
Sort by
Date
Title
Apply sorting
Last updated date between 1/12/2021 and 30/6/2022
Remove Last updated date between 1/12/2021 and 30/6/2022 filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Daratumumab with bortezomib, melphalan and prednisone for untreated multiple myeloma (terminated appraisal)
TA771
9 February 2022
9 February 2022
Depression in adults: treatment and management
NG222
29 June 2022
29 June 2022
Diabetes in children and young people
QS125
14 July 2016
31 March 2022
Diroximel fumarate for treating relapsing–remitting multiple sclerosis
TA794
8 June 2022
8 June 2022
Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency
TA779
16 March 2022
16 March 2022
Dupilumab for treating severe asthma with type 2 inflammation
TA751
8 December 2021
8 December 2021
Durvalumab for maintenance treatment of unresectable non-small-cell lung cancer after platinum-based chemoradiation
TA798
22 June 2022
22 June 2022
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules
DG46
23 February 2022
23 February 2022
Elosulfase alfa for treating mucopolysaccharidosis type 4A
HST19
20 April 2022
20 April 2022
Empagliflozin for treating chronic heart failure with reduced ejection fraction
TA773
9 March 2022
9 March 2022
Previous page
1
2
Current page
3
4
5
…
14
Page
3
of
14
Next page
Results per page
10
25
50
All
Back to top